Replies to post #796899 on NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

This trial:
Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma

https://clinicaltrials.gov/study/NCT04201873?lat=34.0648474&lng=-118.4471591&locStr=UCLA%20Medical%20Center,%20Medical%20Plaza,%20Los%20Angeles,%20CA&distance=50&cond=ATL%20dc&rank=1

And please note, LL’s comment was made in May 2024.